Key result
Patients with cardiomyopathy and VT/TWA had significantly greater endocardial (P<0.005) and epicardial (P<0.05) repolarization heterogeneity than those without VT/TWA.
Why the study?
Is ventricular repolarization heterogeneity greater in cardiomyopathy patients with ventricular arrhythmia vulnerability compared to those without?
Population
22 patients with cardiomyopathy, including 12 with ventricular arrhythmia vulnerability and 10 without.
Design
Cross-sectional
Authors
Loading...
May signal reentrant substrate in cardiomyopathy; hypothesis-generating, needs prospective validation before clinical use.
Observational (n=22)
Is ventricular repolarization heterogeneity greater in cardiomyopathy patients with ventricular arrhythmia vulnerability compared to those without?
p-value: p=<0.005
Patients with cardiomyopathy and ventricular arrhythmia vulnerability exhibit greater endocardial and epicardial repolarization heterogeneity, providing a potential substrate for reentrant arrhythmias.
Chauhan et al. (2005) conducted an observational in Cardiomyopathy and ventricular arrhythmia vulnerability (n=22). Ventricular arrhythmia vulnerability (VT/TWA) vs. No ventricular arrhythmia vulnerability (no VT/TWA) was evaluated on Endocardial and epicardial repolarization time (RT) dispersion (p=<0.005). Patients with cardiomyopathy and VT/TWA had significantly greater endocardial (P<0.005) and epicardial (P<0.05) repolarization heterogeneity than those without VT/TWA.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: